KELLY COLEMAN: Open Payments
NPI 1801907746 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 42 payments from 10 companies in 2025. Trend: 2023 $616 · 2024 $796 · 2025 $1,103
Food & beverage: $1,074Education: $29
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $445 |
| ABBVIE INC. | 12 | $186 |
| Madrigal Pharmaceuticals | 3 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $36 |
| Gilead Sciences, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 3 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: TREMFYA, REZDIFFRA, LINZESS, EOHILIA, ENTYVIO, VOQUEZNA, RINVOQ, DUPIXENT.
Industry payments across NY — which companies pay providers there.
